Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05242822
Title A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Kinnate Biopharma
Indications

Advanced Solid Tumor

Therapies

KIN-3248

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST